The Market Tells Opioid Drugmakers to Settle Up

The markets are sending a message to drugmakers facing opioid litigation: Settle up. Johnson & Johnson late Tuesday announced its first legal settlement over the pharmaceutical giant’s alleged role in spurring the opioid crisis, a modest $20 million deal with two Ohio counties. The agreement will see it avoid a risky trial later this month and the company’s stock rose as much as 3.6% in early trading. (Wash. Post)

Read Full Article